FEDERAL STREET STRATEGIES, LLC

Lobbying for BRISTOL MYERS SQUIBB COMPANY · Global biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Access to prescription drugs. Policies related to 340B. Drug Pricing reform/implementation. Food is Medicine initiatives. Issues related to the budget and appropriations process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.